pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Sirnaomics is a biopharmaceutical company discovering and developing novel targeted therapeutics for critical human diseases by using RNA interference (RNAi) technology.

LOCATION

  • Gaithersburg, MD, USA

  • Cambridge, MA, USA

  • Suzhou, , China

    • THERAPEUTIC AREAS

  • Fibrotic DIsease

  • Oncology

    • WEBSITE

    https://new.sirnaomics.com/

    CAREER WEBSITE

    https://www.sirnaomics.net/careers

    SOCIAL MEDIA

    INVESTORS

    huakong-equity-investment qianhai-shenghui-investment sangel-biomedical-venture-capital value-measured-investment-llimited yuexiu-new-industrial-investment

    PRESS RELEASES


    Dec 30, 2021

    Sirnaomics Ltd., the RNA Therapeutics Biopharmaceutical Company with Strong Presence in Both US and China, Successfully Listed on Main Board of SEHK


    Dec 14, 2021

    Sirnaomics Strengthens Its Development and Manufacturing Leadership with Promotions of Two Biopharma Veterans, Dr. Steven Long and Dr. Edward Wang


    Oct 18, 2021

    Sirnaomics to Present STP705, the Company's Lead Drug Candidate, for the Treatment of Cutaneous Squamous Cell Carcinoma in situ, at the 2021 Fall Clinical Dermatology Conference


    Sep 22, 2021

    Sirnaomics, Inc. to Present at TIDES USA 2021


    Jul 14, 2021

    Sirnaomics Doses First Patient in Phase 2 Study of STP705 for Keloid Scar Prevention


    For More Press Releases
    Google Analytics Alternative